Ceftibuten Pregnancy and Breastfeeding Warnings

Brand names: Cedax

Ceftibuten Pregnancy Warnings

This drug should be used during pregnancy only if clearly needed.

US FDA pregnancy category: B

Animal studies have failed to reveal evidence of fetal harm. There are no controlled data in human pregnancy.

US FDA pregnancy category B: Animal reproduction studies have failed to demonstrate a risk to the fetus and there are no adequate and well-controlled studies in pregnant women.

See references

Ceftibuten Breastfeeding Warnings

Use is considered acceptable; caution is recommended.

Excreted into human milk: Yes (in small amounts)

Comments:
-Low levels in milk are not expected to cause harmful effects in the nursing infant.
-Disruption of infant's gastrointestinal flora (resulting in diarrhea or thrush) reported occasionally with cephalosporins, but such effects have not been adequately evaluated.
-Other cephalosporins have been considered compatible with breastfeeding by the American Academy of Pediatrics.

After a single 200 mg oral dose in 6 women, this drug was undetectable (less than 1 mg/L) at any time up to 24 hours after dosing.

See references

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer